Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation
The paper considers the specific features of the course and therapy of cancer of the corpus uteri on the basis of some clinical and biological characteristics of the tumor. The objective of ongoing and future clinical trials is to expand the arsenal of active drugs and to individualize therapy in pa...
Saved in:
Main Author: | E. V. Artamonova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/183 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor markers in the treatment of patients with gastric cancer
by: A. F. Chernousov, et al.
Published: (2013-06-01) -
THE ROLE OF MOLECULAR-GENETIC MARKERS IN THE DETERMINING OF SURGICAL TREATMENT OF STOMACH CANCER PATIENTS
by: I. I. Bykov
Published: (2012-03-01) -
Tumor markers in the diagnosis of cancer of the corpus uteri (a review of literature)
by: D. B. Olkin, et al.
Published: (2014-07-01) -
Molecular markers of endometrial cancer (review of literature)
by: N. E. Levchenko, et al.
Published: (2014-07-01) -
Significance of ultrasound morphological comparisons in the complex ultrasound diagnosis of the cervix uteri
by: M. A. Chekalova, et al.
Published: (2014-08-01)